Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-16T16:06:16.473Z Has data issue: false hasContentIssue false

Psychoemotional distress on patients with cutaneous manifestations and SARS-CoV-2 infection

Published online by Cambridge University Press:  19 July 2023

C. Sapaniuc*
Affiliation:
Infectious Diseases, “Sf. Paracheva” Infectious Diaseases Clinical Hospital Infectious Diseases, “Grigore T. Popa” University of Medicine and Pharmacy
M. Rascanu
Affiliation:
Psychologist
D. Bran
Affiliation:
Psychologist
G. A. Lacatusu
Affiliation:
Infectious Diseases, “Sf. Paracheva” Infectious Diaseases Clinical Hospital Infectious Diseases, “Grigore T. Popa” University of Medicine and Pharmacy
F. M. Rosu
Affiliation:
anesthesia and intensive care, “Sf. Paracheva” Infectious Diaseases Clinical Hospital anesthesia and intensive care, “Grigore T. Popa” University of Medicine and Pharmacy
M. Pulbere
Affiliation:
dermatologist, “Sf. Paracheva” Infectious Diaseases Clinical Hospital
L. Gheuca-Solovastru
Affiliation:
dermatologist, “Grigore T. Popa” University of Medicine and Pharmacy dermatologist, “Sf. Spiridon” Emergency Hospital, Iasi, Romania
D. C. Manciuc
Affiliation:
Infectious Diseases, “Sf. Paracheva” Infectious Diaseases Clinical Hospital Infectious Diseases, “Grigore T. Popa” University of Medicine and Pharmacy
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The new coronavirus had a huge impact on individuals from a social, economical and psychological point of view. In march 2020 The World Health Organization declared the coronavirus diseases 2019 (COVID-19) a pandemic and highlighted its psychoemotional implications.

Objectives

The aim of this study was to investigate the psychological distress during the COVID-19 pandemic in patients with cutaneous manifestations and SARS-CoV-2 infection.

Methods

Data was collected from one first-line infectious diseases hospital from northeastern Romania. All patients with cutaneous manifestations and SARS-CoV-2 infection who accepted to answer the quality of life questionnaire (QLQ) were included in the study. The descriptive data analysis was conducted with the SPSS.

Results

A total of 191 patients with cutaneous manifestations and COVID-19 completed a questionnaire concerning their psychological distress and financial burden during the pandemic. Patients with chronic dermatological diseases (psoriasis) – 31% reported the highest level of psychological distress and financial burden compared to patients with acute cutaneous manifestations (chickenpox, dermatitis, infectious mononucleosis, steven-johnson syndrome, etc.). Furthermore, this patients showed generalized anxiety disorder, depressive symptoms, post-traumatic stress disorder (PTSD), sleep disturbances and they attributed their individual psychological distress to the COVID-19 pandemic. This patients received psychological/psychotherapeutic treatment due to the COVID-19 crisis, during hospitalization and after discharge.

Conclusions

During the pandemic, patients with dermatological diseases needs not only medical support but also psychological and psychosocial support. This study results emphasize the importance of monitoring the psychological impact of the COVID-19 pandemic on patients with cutaneous manifestations.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.